Ensign Peak Advisors’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-43,112
| Closed | -$553K | – | 2174 |
|
|
2022
Q3 | $553K | Buy |
43,112
+1,490
| +4% | +$19.1K | ﹤0.01% | 1401 |
|
|
2022
Q2 | $550K | Buy |
41,622
+40,432
| +3,398% | +$534K | ﹤0.01% | 1423 |
|
|
2022
Q1 | $25K | Buy |
+1,190
| New | +$25K | ﹤0.01% | 2167 |
|
|
2021
Q4 | – | Sell |
-1,294
| Closed | -$33K | – | 2237 |
|
|
2021
Q3 | $33K | Hold |
1,294
| – | – | ﹤0.01% | 1843 |
|
|
2021
Q2 | $44K | Sell |
1,294
-4,360
| -77% | -$148K | ﹤0.01% | 1814 |
|
|
2021
Q1 | $220K | Sell |
5,654
-873
| -13% | -$34K | ﹤0.01% | 1719 |
|
|
2020
Q4 | $404K | Hold |
6,527
| – | – | ﹤0.01% | 1641 |
|
|
2020
Q3 | $219K | Buy |
6,527
+2,441
| +60% | +$81.9K | ﹤0.01% | 1659 |
|
|
2020
Q2 | $97K | Hold |
4,086
| – | – | ﹤0.01% | 1631 |
|
|
2020
Q1 | $94K | Sell |
4,086
-4,987
| -55% | -$115K | ﹤0.01% | 1582 |
|
|
2019
Q4 | $256K | Buy |
+9,073
| New | +$256K | ﹤0.01% | 1606 |
|